Article

I don't know anything about cancer

This morning I read a blog, "What does it mean to be a good listener?" and then found out a friend's husband had a recurrence. Sometimes it's ironic how things seem to fit together.The blog explained how you can be a good friend to a person who has cancer, especially if you've never been touched by the disease yourself. The one pet peeve (if you can call it that) I've heard from patients and survivors over and over again in this job--please don't tell me you know how I feel unless you've been here.I haven't. I've never had cancer. I've never been a primary caregiver to someone who has had cancer. Through my work at CURE, though, I've met many people who have had to deal with the disease, including some very good friends--including a colleague and my boss ("Confessions of a two-time survivor"). I can't imagine what they're going through. Nor do I try.Some of the best advice I've heard on what to say to someone just diagnosed with cancer is simply, "I'm sorry." Even if you're afraid of saying the wrong thing (like, I knew someone with ____ cancer, but they died--yeah, never say that), it's better than saying nothing at all. So, to all those people out there who love people with cancer, but don't know what they're going through:"The fact that you don't share the bond of cancer, though, doesn't mean you can't be helpful, supportive, and caring. You can be all of these by listening. Some of the most supportive people in my life have never had cancer. It doesn't matter. They are good friends in part because they are good listeners." --Lisa Adams, breast cancer survivorI don't know anything about cancer, but I am a good listener.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Dr. Masey Ross explains how biomarker testing, patient history, and quality-of-life concerns guide treatment decisions in metastatic breast cancer.
Dr. Paolo Tarantino shares how antibody-drug conjugates deliver more targeted chemo, and how the treatment lasts longer in the body vs traditional therapy.
Image of women with text.
Dr. Breelyn Wilky urged newly diagnosed GIST patients to seek support from peers and advocacy groups, and to consult experts, even if care stays local.
The inMIND trial led to the FDA approval of Monjuvi with Revlimid and Rituxan for relapsed follicular lymphoma, showing benefits across diverse patients.
Clinical Trial Evaluating Monjuvi in Lymphoma Gives Lasting Responses
Survivors can find strength after cancer by focusing on goals, loved ones, and spiritual connection, especially during challenging or uncertain times.
Image of man with text.